units of unit cost resource per Proportion Setting in Number of (Oncologist, resource is per patient budget cost Respiratory Physician) provided receiving MBS Safety provided relevant resource nets* Private Provider of resource of patients in time provided in health receiving horizon Other govt which submission insurer To be in Clinical monitoring (radiological or other provided in submission imaging, blood counts submission etc) public and in Treatment of adverse private submission events hospitals Hospitals / MBS / PBS To be provided in Blend of inpatient/ submission outpatient and Pharmaceuticals To in (crizotinib, pemetrexed be provided submission in or docetaxel, relevant pre-medications/ submission concomitant therapies) Resources used to manage patients successfully treated with the proposed intervention above As above (with the See exception of crizotinib above costs) See above As above (with the exception of crizotinib costs)
Setting in Proportion Number of units of resource per unit cost (Oncologist, Respiratory Physician) Provider of resource which resource is provided of patients receiving provided in relevant time horizon per patient receiving resource provided in submission MBS Safety nets* Other govt budget Private health insurer cost Clinical monitoring (radiological or other imaging, blood counts etc) To be provided in submission in submission Treatment of adverse events Hospitals / MBS / PBS Blend of inpatient/ outpatient and public and private hospitals To be provided in submission in submission Pharmaceuticals (crizotinib, pemetrexed or docetaxel, relevant pre-medications/ concomitant therapies) To be provided in submission in submission Resources used to manage patients successfully treated with the proposed intervention As above (with the exception of crizotinib costs) above See above See above As above (with the exception of crizotinib costs)
1250-ALK-Final%20DAP-accessible.docx